In Vitro and In Vivo Efficacies of the Linear and the Cyclic Version of an All-d-Enantiomeric Peptide Developed for the Treatment of Alzheimer’s Disease

Multiple sources of evidence suggest that soluble amyloid β (Aβ)-oligomers are responsible for the development and progression of Alzheimer’s disease (AD). In order to specifically eliminate these toxic Aβ-oligomers, our group has developed a variety of all-d-peptides over the past years. One of the...

Descripción completa

Detalles Bibliográficos
Autores principales: Schemmert, Sarah, Camargo, Luana Cristina, Honold, Dominik, Gering, Ian, Kutzsche, Janine, Willuweit, Antje, Willbold, Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234218/
https://www.ncbi.nlm.nih.gov/pubmed/34207233
http://dx.doi.org/10.3390/ijms22126553

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8234218/
https://www.ncbi.nlm.nih.gov/pubmed/34207233
http://dx.doi.org/10.3390/ijms22126553

Ejemplares similares